NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We do
    • Strategic Partnership Board
    • Steering Committee
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
  • Patient & Public Involvement
        • About Patient & Public Involvement

        • Our work with patients and the public
        • Our Work with Schools
        • Patient Involvement Blog
        • External Links
        • For Patients, Carers & Members of the Public

        • About Patients Active in Research
        • Listings for Patients Active in Research
        • Register interest in involvement
        • Patient and Public Involvement Workshops 2019/20
        • Oxford Blood Group (within Haematology & Stem Cells research theme)
        • For Researchers

        • PPI Strategy
        • A Researcher's Guide to PPI
        • PPI Resources for Researchers
        • PPI Briefing Notes for Researchers
        • PPI Case Studies
        • Post a Listing for Patient & Public Involvement
  • Professional & Training
        • Professional Partnerships
        • Case Studies – Early Careers Researchers
          • Early Career Profile: Teresa Lambe
          • Early Career Profile: Dr Jasmina Cehajic Kapetanovic
          • Early Career Profile: Sara Khalid
          • Early Career Profile: Chantal Hargreaves
          • Early Career Profile: Kate Tudor
        • Useful Links
        • Research Education and Training
        • Support from the NIHR Oxford BRC
          • Oxford BRC Small Grants in Health Sciences
          • Doctoral awards for nurses, midwives and allied health professionals
          • Senior Fellows Competition
          • Training bursaries for affiliated research nurses, midwives, scientists and allied health professionals
          • Preparatory research career fellowships for nurses, midwives and allied health professionals
        • Funding from other Providers
        • Training Opportunities
        • Education Resources
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Genomic Medicine > Oxford meeting looks at legacy of 100,000 Genomes Project and what comes next

Oxford meeting looks at legacy of 100,000 Genomes Project and what comes next

1 March 2019 · Listed under Genomic Medicine

Tweet about this on Twitter
Twitter
Share on Facebook
Facebook
Share on LinkedIn
Linkedin
Share

A meeting involving clinicians, academics and patients has taken place in Oxford to celebrate the successes of the 100,000 Genomes Project and how genomic medicine becomes a routine part of NHS care in future.

Prof Dame Sue Hill outlined the new NHS Genomic Medicine Service.

The meeting, held on 28 February, Rare Diseases Day, at the University of Oxford’s Richard Doll Building, was organised by the Oxford Genomic Medicine Centre, based at Oxford University Hospitals. Among the speakers were Sir John Bell, Regius Professor of Medicine at the University of Oxford and Professor Dame Sue Hill, Chief Scientific Officer for NHS England, who praised the “significant contribution to the national programme” made by Oxford .

Two leading members of the NIHR Oxford Biomedical Research Centre’s Genomic Theme – Professors Jenny Taylor, from the Wellcome Centre for Human Genetics, and Professor Hugh Watkins, Head of the Radcliffe Department of Medicine, also spoke at the event.

Dr Edward Blair, Clinical Director of the Oxford NHS Genomics Medicine Centre (GMC), who chaired the event, said: “The reason we’re here today is to celebrate Oxford’s achievements in the 100,000 Genomes Project and our ongoing success from being part of this programme. We recruited over 6,000 patients to the project, and given that we only made up 5% of the national population, that’s a remarkable achievement.

“We’ve helped drive new diagnoses for patients, helped deliver a massive research agenda and we’re taking this into the NHS as part of the new national Genomic Medicine Service, which we’re hearing lots about today.”

Oxford was the biggest recruiter nationally for haematological cancers, and far exceeded its target for recruitment of patients with rare diseases.

Sir John Bell recalls the creation of the 100,000 Genomes project and how genomics is fundamental to the future NHS

Sir John Bell recalled how a group of genomic scientists, who had already been testing whole genome sequencing in clinical diagnostics, convinced the then Prime Minister David Cameron in 2011 to fund the 100,000 Genomes Project.

“This was a high risk project, but it has produced what I consider to be a remarkable state – this is the world-leading example of a genetic diagnostic programme in a healthcare system delivering data at scale,” he said. “No other country in the world is operating at this level.”

He pointed out that the UK – and Oxford – was also making great strides in the fields of digital pathology and artificial intelligence, which, when used in conjunction with genomics made the UK “uniquely placed in this space”.

Sir John, a leading figure in the UK’s new life sciences industrial strategy, explained that genomics is fundamental to the strategy, both in terms of economic growth, especially in the growing digital health field, but it could also underpin a “new paradigm for healthcare”, based on earlier diagnosis.

One of the clearest examples of the legacy of the 100,000 Genomes Project was the announcement last October by the Health and Social Care Secretary Matt Hancock that the one million whole genomes would be sequenced over the next five years, half of them in the NHS.

Dame Sue Hill recalled that the aim for the NHS of taking part in the 100,000 Genomes Project was to “drive transformation in the service” and develop a new model for care. She noted the close alignment between research and clinical care, which would, she said, be the bedrock of the new Genomic Medicine Service.

“In terms of the project and the future, we developed the clinical leadership that is required for change and started to understand the level of workforce upskilling we require if we really want to mainstream genomics into healthcare,” she said.

What was also crucial, Dame Sue said, was the capture of large amounts of patient data that could allow us to better understand genomic variants and be used in future research. “We used this project to build the evidence of what we needed to do for the future” in terms of building the confidence of patients to see the benefits of sharing their data for purposes beyond their immediate clinical care. This will be a feature of the new service in order to build a genomics research database whose benefits will feed back into the NHS.

Dame Sue praised the role of the NIHR, especially the Oxford BRC and the Clinical Research Network, in supporting the project.

Under the new Genomic Medicine Service, Oxford falls under the Wessex and West Midlands Genomic Laboratory Hub (GLH), based at Birmingham Women’s and Children’s NHS Foundation Trust. It will be one of seven GLHs, working together as a national testing system that will continue to test for rare diseases and some cancers, and will over time be expanded to include other common diseases.

Around 170 people attended the event. Speakers at the event included parents of patients with rare diseases who had benefited from taking part in the 100,000 Genomes Project, among them Katrin Gebhard, from Buckingham.

Katrin Gebhard

Katrin’s six-year-old son Nic was diagnosed with Wiedemann-Steiner syndrome, which affects just a few hundred people worldwide.

Following several years of inconclusive GP and hospital visits, it was suggested by the clinical teams at OUH that they take part in the 100,000 Genomes Project.

“For us it was a welcome opportunity to get everything checked. Until then it’s so vague; you are just guessing. When you find out definitely what it is, you have a name for it and you can deal with it. When we found it his diagnosis, it was just relief,” Kat said. “A lot of little things started to make sense. It sounds silly, but it meant it was not my fault. It wasn’t a result of something I’d done or hadn’t done.”

The 100,000 Genomes Project is still working to return results to all participants nationwide and it’s hoped that hundreds of patients locally will be helped by new information, with thousands more benefiting from the advances in medical research made possible by the project in future.

← World’s first gene therapy operation for common cause of sight loss carried out
Genes and height matter for carpal tunnel syndrome →

News

  • All-singing all-dancing research at the Oxford Science and Ideas Festival 31 October 2019
  • Promising therapy for common form of eczema identified in early-stage trial 24 October 2019
  • Severe reactions to grief can be predicted and treated in the first months following a bereavement 8 October 2019
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Cookies

This site uses cookies See our data control and privacy page